37 search results for: biomarkers

Dr. Elliot Israel presents the utility of eosinophils as a biomarker of type 2 inflammation and their role in the disease burden of asthma.

This infographic outlines how endotyping, phenotyping, and genotyping are interrelated concepts that are crucial for improving the way patients with COPD are characterized and how understanding these concepts can better optimize patient care

Examine underlying type 2 inflammation as a driver of airway hyperresponsiveness in patients with asthma.

Learn how to identify chronic obstructive pulmonary disease (COPD) patients with type 2 inflammation using blood eosinophil (EOS) levels, understand the associated risks, and recognize factors that may influence EOS counts.

Examine underlying type 2 inflammation as a driver of airway hyperresponsiveness in patients with asthma.

Learn about FEV1pp and the downstream effects of lung function decline in children with severe asthma.

Review a patient case to learn more about identifying uncontrolled asthma and type 2 inflammation in pediatric patients

Dr. Leonard Bacharier discusses how type 2 inflammation underlies the pathophysiology of pediatric severe asthma and contributes to burden.

Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.